CSIMarket
 


Longeveron Inc   (LGVN)
Other Ticker:  
 
 

LGVN's Income from Cont. Operations Growth by Quarter and Year

Longeveron Inc 's Income from Cont. Operations results by quarter and year




LGVN Income from Cont. Operations (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 9.87 0.00 0.00
III Quarter September - -4.86 0.00 0.00
II Quarter June -5.62 -5.01 0.00 0.00
I Quarter March -3.51 0.00 0.00 0.00
FY   -9.13 0.00 0.00 0.00



LGVN Income from Cont. Operations second quarter 2022 Y/Y Growth Comment
Longeveron Inc in the second quarter 2022 recorded loss from continued operations of $ -5.62 millions.

According to the results reported in the second quarter 2022, Longeveron Inc achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Longeveron Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the second quarter 2022.




LGVN Income from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Longeveron Inc 's second quarter 2022 Income from Cont. Operations $ -5.62 millions LGVN's Income Statement
Longeveron Inc 's second quarter 2021 Income from Cont. Operations $ -5.01 millions Quarterly LGVN's Income Statement
New: More LGVN's historic Income from Cont. Operations Growth >>


LGVN Income from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Longeveron Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LGVN's II. Quarter Q/Q Income from Cont. Operations Comment
II. Quarter 2022 results of -5.62 millions by Longeveron Inc look even more unfavourable considering the -3.51 millions a quarter before.

Within Major Pharmaceutical Preparations industry Longeveron Inc achieved highest sequential Income from Cont. Operations growth. While Longeveron Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LGVN's II. Quarter Q/Q Income from Cont. Operations Comment
Current results of -5.62 millions by Longeveron Inc come out even more unfavourable considering the -3.51 millions in the first quarter.

Within Major Pharmaceutical Preparations industry Longeveron Inc achieved highest sequential Income from Cont. Operations growth. While Longeveron Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Longeveron Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Income from Cont. Operations 12 Months Ending $ -4.12 $ -4.12 $ -3.51 $ 0.00 $ 0.00
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Longeveron Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -4 millions in the Sep 30 2022 period.
The business is worsening as the cumulative loss from continued operations is getting bigger from $ -3.51 millions in the twelve months ending a quarter before and $ -3.51 millions for the twelve months ending in the quarter a year ago.

Longeveron Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Longeveron Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -4 millions in the Sep 30 2022 period.
The situation is worsening as the cumulative loss from continued operations is becoming larger from $ -3.51 millions in TTM ending quarter Jun 30 2022 and $ -3.51 millions for the twelve months ending in the quarter Sep 30 2021 Lucy  Davies mentioned.

Longeveron Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
LGVN's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for LGVN's Competitors
Income from Cont. Operations Growth for Longeveron Inc 's Suppliers
Income from Cont. Operations Growth for LGVN's Customers

You may also want to know
LGVN's Annual Growth Rates LGVN's Profitability Ratios LGVN's Asset Turnover Ratio LGVN's Dividend Growth
LGVN's Roe LGVN's Valuation Ratios LGVN's Financial Strength Ratios LGVN's Dividend Payout Ratio
LGVN's Roa LGVN's Inventory Turnover Ratio LGVN's Growth Rates LGVN's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Jun 30 2022 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Jun 30 2022
Abbvie Inc 20.68%$ 20.676 millions
Utah Medical Products Inc19.76%$ 19.761 millions
Zynex inc 19.16%$ 19.160 millions
Avantor Inc 18.76%$ 18.758 millions
Chemed Corporation17.58%$ 17.575 millions
Maravai Lifesciences Holdings Inc 16.66%$ 16.656 millions
Mettler Toledo International Inc14.78%$ 14.779 millions
Ensign Group Inc14.27%$ 14.274 millions
Stryker Corp10.81%$ 10.811 millions
Zimmer Biomet Holdings Inc 8.07%$ 8.070 millions
Incyte Corporation8.01%$ 8.013 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CRVW's Profile

Stock Price

CRVW's Financials

Business Description

Fundamentals

Charts & Quotes

CRVW's News

Suppliers

CRVW's Competitors

Customers & Markets

Economic Indicators

CRVW's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071